Eupraxia Pharmaceuticals, Inc. EPRX
NASDAQ · United States · Health Technology
$7.24-0.59 (-7.54%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.22 | -0.22 | +1.4% | $0 | — | -2.7%$6.66→$6.48 |
| Q1 2026 | 2026-05-12 | -0.23 | -0.22 | -4.5% | — | — | +1.8%$7.42→$7.55 |
| Q4 2025 | 2026-03-12 | -0.37 | -0.16 | -131.3% | — | — | -4.3%$7.69→$7.36 |
| Q3 2025 | 2025-11-04 | -0.19 | -0.23 | +17.4% | — | — | -6.9%$6.09→$5.67 |
| Q4 2024 | 2025-03-20 | -0.23 | -0.16 | -43.8% | — | — | — |
| Q4 2023 | 2024-04-01 | -0.32 | -0.18 | -77.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.